gene

AMYLOID

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7024Connections
9Hypotheses
25Analyses
50Outgoing
50Incoming

Summary

AMYLOID is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 2116 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolAMYLOID
SummaryPage for A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer's)
Associated DiseasesALS, ALZHEIMER'S DISEASE, AMYLOID PLAQUES, Aging, Alzheimer
Known Drugs/CompoundsLECANEMAB, DONANEMAB, RAPAMYCIN, SEMAGLUTIDE, NICOTINAMIDE, Tirzepatide
InteractionsALZHEIMER'S DISEASE, GENES, ALZHEIMER, BACE1, CYTOKINES, NEURODEGENERATIVE DISORDERS
KG Connections5145 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer's)

clinical · 1110 words

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        AMYLOID["AMYLOID"] -->|"associated with"| MICROGLIA["MICROGLIA"]
        AMYLOID["AMYLOID"] -->|"associated with"| TAU["TAU"]
        AMYLOID["AMYLOID"] -->|"associated with"| BACE1["BACE1"]
        AMYLOID["AMYLOID"] -->|"associated with"| AUTOPHAGY["AUTOPHAGY"]
        AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
        AMYLOID["AMYLOID"] -->|"associated with"| GFAP["GFAP"]
        AMYLOID["AMYLOID"] -->|"associated with"| NEURON["NEURON"]
        AMYLOID["AMYLOID"] -->|"associated with"| SOD1["SOD1"]
        AMYLOID["AMYLOID"] -->|"associated with"| NLRP3["NLRP3"]
        AKT["AKT"] -->|"associated with"| AMYLOID["AMYLOID"]
    end
    subgraph Signaling["Signaling"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER["ALZHEIMER"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER_S_DISEASE_1["ALZHEIMER'S DISEASE"] -.->|"inhibits"| AMYLOID["AMYLOID"]
        ALZHEIMER_2["ALZHEIMER"] -.->|"inhibits"| AMYLOID["AMYLOID"]
    end
    style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style BACE1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style SOD1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (3129)

TargetRelationTypeStr
MICROGLIAassociated_withgene1.00
TAUassociated_withgene1.00
BACE1associated_withgene1.00
AUTOPHAGYassociated_withgene1.00
APOPTOSISassociated_withgene1.00

Incoming (3895)

SourceRelationTypeStr
AKTassociated_withgene1.00
OXIDATIVE STRESSactivatesgene1.00
ALZHEIMER'S DISEASEactivatesgene1.00
ALZHEIMERactivatesgene1.00
ALZHEIMER'S DISEASEinhibitsgene1.00

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop optogenetic targeting PV interneurons to restore 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate 0.610 - Do β-amyloid plaques and neurofibrillary
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli 0.600 - Do β-amyloid plaques and neurofibrillary
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.588 neurodegeneration How does APOE4's beneficial immune funct
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.576 neurodegeneration What are the cell-type-specific transcri
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in 0.458 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.456 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Test: TREM2 enhances amyloid clearance 0.405 - -
Microglial ACE Enhancement for Amyloid Clearance 0.399 neurodegeneration Gene expression changes in aging mouse b

Mentioning Analyses (25)

Scientific analyses that reference this entity

How do sphingomyelin/ceramide ratios specifically regulate BACE1 clustering and

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.596

Are interneuron oscillation deficits compensatory responses or primary pathologi

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.497

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.542

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.544

What signals trigger microglia to specifically recognize and phagocytose LC axon

neuroinflammation | 2026-04-14 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clin [PMID:41324786] Abushakra S, Doraiswamy PM, Hey JA, Tosu CNS drugs 2026 0
Adverse childhood experiences and cardiometabolic risk factors in people with bi [PMID:40935250] Turner A, Kuperberg M, McGovern H, Wrobe J Affect Disord 2026 0
Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomark [PMID:41198173] Prasad R, Adu-Rutledge Y, Ziani B, Floyd Gut 2026 0
Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease. [PMID:41329157] Smyth LCD, Verhaege D, Standen-Bloom E, J Exp Med 2026 0
A minimally invasive dried blood spot biomarker test for the detection of Alzhei [PMID:41491101] Huber H, Montoliu-Gaya L, Brum WS, Vávra Nat Med 2026 0
[Polypharmacy and nephrotoxicity]. [PMID:41535444] Czock D, Ebinger K, Sommerer C Inn Med (Heidelb) 2026 0
Association between sleep duration and fluid biomarkers of Alzheimer's disease: [PMID:41610733] Young VM, Zeynoun J, Ruiz Laza A, Salard Sleep Med Rev 2026 0
Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. [PMID:41618732] Kantarci K, Kara F, Tosakulwong N, Fough Alzheimers Dement 2026 0
Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean comm [PMID:41691306] Orellana P, Henríquez F, Cabral-Miranda Alzheimers Res Ther 2026 0
Neuro-renin-angiotensin-aldosterone system axis in alzheimer's disease: from mol [PMID:41706377] Singh G, Maparu K, Aran KR Metab Brain Dis 2026 0
Renin-angiotensin system blockade attenuates brain mitochondrial dysfunction, ox [PMID:41883437] García Menéndez S, Inserra F, de Cavanag World J Exp Med 2026 0
Association Between ACE (I/D) Polymorphism and Essential Hypertension (EH): An U [PMID:41899774] Smallwood A, Akam E, Hunter DJ, Singh M, Int J Environ Res Public Healt 2026 0
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR): a rand [PMID:41932694] Pepine CJ, Handberg E, Cooper-DeHoff R, Open Heart 2026 0
Renin-Angiotensin-Aldosterone Medication Use and Outcomes in Injured Patients Re [PMID:41936145] Werenski HE, Diz DI, Chappell MC, Hoth J J Surg Res 2026 0
Characteristics of reproductive tract microbiota in health and disease. [PMID:41936969] Han Q, Wang N, Feng T, Li YY, Zhu Z et a Microb Pathog 2026 0
Novel_circ_002651 regulates the immune defense of eastern honeybee larvae agains [PMID:41940497] Zhang K, Wang F, Fan N, Fan X, Wu T et a Virulence 2026 0
Safety and tolerability of the ACE-inhibitor lisinopril among Nigerian adults wi [PMID:41945136] Dankishiya FS, Muhammad H, Wudil UJ, Mus Naunyn Schmiedebergs Arch Phar 2026 0
Ace in the hole: playing cards show the role of order and magnitude in the SNARC [PMID:41945148] Mingolo S, Prpic V, Cipora K, Bilotta E, Psychol Res 2026 0
Feasibility of implementing an auditory rehabilitation program for older adults [PMID:41945417] Torrente MC, Vasquez C, Bravo R, Miranda Acta Otolaryngol 2026 0
Spatial distribution and health risk assessment of heavy metals in soils around [PMID:41954659] Tengbeh AS, Akande IO, Offor CC, Abdulai Environ Geochem Health 2026 0